Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2023-03-09 |
2022-12 |
-0.33 |
N/A |
N/A |
N/A |
2022-11-14 |
2022-09 |
-0.38 |
N/A |
N/A |
N/A |
2022-08-15 |
2022-06 |
-0.3 |
N/A |
N/A |
N/A |
2022-05-12 |
2022-03 |
-0.08 |
N/A |
N/A |
N/A |
2022-03-10 |
2021-12 |
-0.55 |
N/A |
N/A |
N/A |
2021-11-11 |
2021-09 |
-0.51 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2021-05-04 |
William Blair |
Downgrade |
Outperform |
Market Perform |
2021-04-13 |
B of A Securities |
Downgrade |
Buy |
Underperform |
2021-03-02 |
B of A Securities |
Upgrade |
|
Neutral |
2021-03-02 |
William Blair |
Upgrade |
|
Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2022-12-19 |
ALLEN ANTHONY JOSEPH |
Chief Operating Officer |
144.93K |
Sale |
2022-11-24 |
COLLINS KEVIN WALTER |
Officer |
346.72K |
Sale |
2022-09-14 |
ENGELSON ERIK T. |
Chief Executive Officer |
321.39K |
Purchase |
2022-09-15 |
GEORGE DANIEL |
Chief Financial Officer |
46.01K |
Sale |
2021-06-17 |
HARTMANN HANSGREGORY C |
Chief Operating Officer |
100.00K |
Stock Award(Grant) |
2023-02-15 |
KASHMOLAH GHAZI |
Officer |
134.07K |
Sale |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2022-12-30 |
Eclipse Ventures, LLC |
6.22M |
2.82M |
15.52% |
2022-12-30 |
EPIQ Capital Group, LLC |
725.68K |
328.22K |
1.81% |
2022-12-30 |
Vanguard Group, Inc. (The) |
623.49K |
282.00K |
1.55% |
2022-12-30 |
Citigroup Inc. |
436.84K |
197.58K |
1.09% |
2022-12-30 |
Balyasny Asset Management LLC |
271.03K |
122.59K |
0.68% |
2022-12-30 |
Morgan Stanley |
207.76K |
93.97K |
0.52% |
Report Date |
Organization |
Position |
Value |
Percentage |
2022-09-29 |
Vanguard Total Stock Market Index Fund |
464.75K |
210.20K |
1.16% |
2022-09-29 |
Mutual Fund Ser Tr-AlphaCentric LifeSci Healthcare Fund |
320.20K |
144.83K |
0.80% |
2022-09-29 |
Vanguard Extended Market Index Fund |
130.09K |
58.84K |
0.32% |
2022-09-29 |
Bridgeway Funds Inc-Ultra Small Company Market Fund |
110.50K |
49.98K |
0.28% |
2022-11-29 |
Fidelity Extended Market Index Fund |
46.41K |
20.99K |
0.12% |
2022-12-30 |
iShares Micro Cap ETF |
38.20K |
17.28K |
0.10% |